Aytu BioPharma, Inc. (AYTU) Options Greeks

Options Greeks measure sensitivity to various factors: Delta (price), Gamma (delta change), Theta (time decay), and Vega (volatility). They are essential for risk management and position sizing.

Aytu BioPharma, Inc. (AYTU) operates in the Healthcare sector, specifically the Drug Manufacturers - Specialty & Generic industry, with a market capitalization near $18.5M, listed on NASDAQ, employing roughly 102 people, carrying a beta of 0.28 to the broader market. Aytu Biopharma, Inc. Led by Joshua R. Disbrow, public since 2008-09-25.

Options Greeks analysis provides sensitivity measures for price, time, and volatility. No recent options activity for AYTU as of 2026-06-02; this typically reflects low options liquidity, a recently listed name, or a temporary data feed delay. Snapshot will refresh on the next active session.

Learn how options Greeks is reported and how to read the data →